Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Volcanic ash: toxicity to isolated lung cells.

V Castranova, L Bowman, J M Shreve

    Journal of Toxicology and Environmental Health
    |February 1, 1982
    PubMed
    Summary

    Mount St. Helens volcanic ash exposure may impair lung defenses. Studies show ash inhibits superoxide release from alveolar macrophages, potentially reducing the lungs' ability to fight infection.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Long-term safety and efficacy of anacetrapib in patients with atherosclerotic vascular disease.

    European heart journal·2021
    Same author

    Corrigendum to 'Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib: Patient-focused outcome results from the randomised phase III REACH study' [Eur J Canc 81 (2017) 17-25].

    European journal of cancer (Oxford, England : 1990)·2018
    Same author

    Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib: Patient-focused outcome results from the randomised phase III REACH study.

    European journal of cancer (Oxford, England : 1990)·2017
    Same author

    Randomized Evaluation of the Effects of Anacetrapib through Lipid-modification (REVEAL)-A large-scale, randomized, placebo-controlled trial of the clinical effects of anacetrapib among people with established vascular disease: Trial design, recruitment, and baseline characteristics.

    American heart journal·2017
    Same author

    Lung cancer screening and management.

    Minerva medica·2015
    Same author

    Soluble guanylate cyclase: a new therapeutic target for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.

    Clinical pharmacology and therapeutics·2015

    Area of Science:

    • Environmental Health
    • Toxicology
    • Pulmonary Medicine

    Background:

    • Volcanic ash from the 1980 Mount St. Helens eruption was collected in Spokane, Washington.
    • Assessing the toxicity of inhaled volcanic ash to lung cells is crucial for understanding respiratory health risks.

    Purpose of the Study:

    • To evaluate the toxicological effects of Mount St. Helens volcanic ash on isolated lung cells.
    • To determine the impact of volcanic ash on key physiological functions of pulmonary cells.

    Main Methods:

    • In vitro and in vivo exposure of rabbit type II pneumocytes and rat alveolar macrophages to volcanic ash.
    • Monitoring oxygen consumption, superoxide release, and membrane integrity of lung cells.
    • Assessing lipid peroxidation in rat lung microsomes.

    Main Results:

    • Volcanic ash showed minimal impact on oxygen consumption and membrane integrity of resting lung cells.
    • No significant lipid peroxidation was observed in rat lung microsomes.
    • Volcanic ash inhibited superoxide anion release from zymosan-stimulated rat alveolar macrophages.

    Conclusions:

    • Inhibition of superoxide release suggests impaired antibacterial function of alveolar macrophages.
    • Exposure to volcanic ash may compromise the lung's defense mechanisms against infection.
    • Further research is needed to fully elucidate the pulmonary health implications of volcanic ash exposure.

    Related Experiment Videos